DOCTOR CARE ANYWHERE GROUP PLC (DOC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

DOC

DOC - DOCTOR CARE ANYWHERE GROUP PLC

FNArena Sector : Healthcare services
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -3.33
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.08

24 Mar
2025

-0.010

OPEN

$0.10

-11.11%

HIGH

$0.10

45,057

LOW

$0.08

TARGET
$0.12 50.0% upside
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL . SLA .
FNARENA'S MARKET CONSENSUS FORECASTS
DOC: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) - 1.0 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in GBP.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-3.9
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx76.2 M
Book Value Per Share xxxxxxxxxxxxxxx-0.4
Net Operating Cash Flow xxxxxxxxxxxxxxx0.7 M
Net Profit Margin xxxxxxxxxxxxxxx-13.06 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-652.25 %
Return on Invested Capital xxxxxxxxxxxxxxx-62.22 %
Return on Assets xxxxxxxxxxxxxxx-29.73 %
Return on Equity xxxxxxxxxxxxxxx-652.25 %
Return on Total Capital xxxxxxxxxxxxxxx-46.17 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx0.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx16 M
Total Debt xxxxxxxxxxxxxxx17 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx9 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx3.2 M
Capex % of Sales xxxxxxxxxxxxxxx4.20 %
Cost of Goods Sold xxxxxxxxxxxxxxx37 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx48 M
Research & Development xxxxxxxxxxxxxxx6 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

17/03/2025

1

Speculative Buy

$0.12

50.00%

Doctor Care Anywhere's FY24 revenue fell short of expectations due to a decline in 2H, prompting Bell Potter to lower its forecast for FY25.

The downgrade (at considerable delay) is mainly on account of an uncertain outlook for volume growth, but the broker regards it as conservative given price growth expectations.

The broker is more optimistic about the outlook over 2-5 years, seeing the recent appointment of industry specialist Laure O'Riordan as a catalyst for acceleration of business beyond AXA PHI.

No change to the 12c target price. Speculative Buy remains.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -0.98 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

DOC STOCK CHART

FNArena News on DOC

1
FNArena Corporate Results Monitor – 03-09-2024

Sep 03 2024 - Australia
2
FNArena Corporate Results Monitor – 01-03-2024

Mar 01 2024 - Australia
3
Weekly Ratings, Targets, Forecast Changes – 16-06-23

Jun 19 2023 - Weekly Reports
4
Australian Broker Call *Extra* Edition – Sep 07, 2022

Sep 07 2022 - Daily Market Reports
5
Health Is Wealth

Jul 27 2022 - Australia

Latest Healthcare services News

1
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
2
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
3
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
4
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
5
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
6
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
7
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
8
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
9
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
10
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps